These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36349502)

  • 1. Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.
    Jaitner S; Pretzsch E; Neumann J; Schäffauer A; Schiemann M; Angele M; Kumbrink J; Schwitalla S; Greten FR; Brandl L; Klauschen F; Horst D; Kirchner T; Jung A
    J Pathol Clin Res; 2023 Jan; 9(1):73-85. PubMed ID: 36349502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
    Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
    Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness.
    Feng Y; Yang Z; Zhang C; Che N; Liu X; Xuan Y
    Pathol Res Pract; 2021 Feb; 218():153323. PubMed ID: 33429327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer.
    Ma HW; Kim JM; Kim DH; Park IS; Kim JH; Park KC; Seo DH; Kim JH; Che X; Kim TI; Cheon JH; Kim SW
    Cancer Gene Ther; 2023 May; 30(5):694-703. PubMed ID: 36577836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer.
    Tang Q; Chen J; Di Z; Yuan W; Zhou Z; Liu Z; Han S; Liu Y; Ying G; Shu X; Di M
    J Exp Clin Cancer Res; 2020 Nov; 39(1):232. PubMed ID: 33153498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced Nur77 activates PI3K/Akt signaling
    Shi Z; To SKY; Zhang S; Deng S; Artemenko M; Zhang M; Tang J; Zeng JZ; Wong AST
    Theranostics; 2021; 11(7):3376-3391. PubMed ID: 33537093
    [No Abstract]   [Full Text] [Related]  

  • 8. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
    Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
    J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactomedin-4 in digestive diseases: A mini-review.
    Wang XY; Chen SH; Zhang YN; Xu CF
    World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers.
    Yu L; Wang L; Chen S
    Neoplasma; 2011; 58(1):9-13. PubMed ID: 21067260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 12. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
    Liu W; Rodgers GP
    Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OLFM4 Inhibits Epithelial-Mesenchymal Transition and Metastatic Potential of Cervical Cancer Cells.
    Li J; Liu C; Li D; Wan M; Zhang H; Zheng X; Jie X; Zhang P; Li J; Hou H; Sun Q
    Oncol Res; 2019 Jul; 27(7):763-771. PubMed ID: 30764901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-enhancer-associated long noncoding RNA AC005592.2 promotes tumor progression by regulating OLFM4 in colorectal cancer.
    Yan L; Chen H; Tang L; Jiang P; Yan F
    BMC Cancer; 2021 Feb; 21(1):187. PubMed ID: 33622275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cells expressing OLFM4 and LGR5 mRNA by in situ hybridization in the yolk sac and small intestine of embryonic and early post-hatch chicks.
    Zhang H; Wong EA
    Poult Sci; 2018 Feb; 97(2):628-633. PubMed ID: 29155957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
    Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
    J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
    Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
    Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial-Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis.
    Ding L; Yang Y; Lu Q; Qu D; Chandrakesan P; Feng H; Chen H; Chen X; Liao Z; Du J; Cao Z; Weygant N
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.